Clinical Trials Browser

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Solid Tumor, Adult

Clinical Trials

ATTEST

First In Human Study of CX-2051 in Advanced Solid Tumors

First In Human Study of CX-801 in Advanced Solid Tumors

GT201 Injection For The Treatment Of Advanced Solid Tumors

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

ImmuCCo

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Okgyn1

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

MEDIPAC

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

CASTLE-11

MoST-TAP

First-in-human Trial of EGL-001 in Patients with Selected Advanced And/or Metastatic Solid Tumors

SprayDye

Anti-cancer DC Cell Vaccination to Treat Solid Tumors

Anti-cancer Neoantigen Polypeptide Vaccine to Treat Solid Tumors

Anti-cancer Neoantigen mRNA Vaccine to Treat Solid Tumors

Development and Application Study of ePRO Software for Managing Cancer Patients Throughout the Treatment Period

A Phase l Study of By101921, an Oral PARP7 Inhibitor, in Patients With Advanced Solid Tumors

Zotatifin

Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors

A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors

A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours